Clinical trial

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating…

NCT00021450 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00021450
Title Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Official title Three Dimensional Conformal Radiotherapy / Intensity Modulated Radiotherapy Alone Vs Three Dimensional Conformal Therapy / Intensity Modulated Radiotherapy Plus Adjuvant Hormonal Therapy In Localized T1b-c, T2a, N0, M0 Prostatic Carcinoma. A Phase III Randomized Study
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Prostate Cancer
Intervention type Drug, Procedure, Radiation
Interventions bicalutamide, goserelin acetate, adjuvant therapy, radiation therapy
Enrollment 819
Start date Apr 1, 2001
Primary completion Apr 1, 2008
Completion Jan 1, 2016
First posted Jan 27, 2003
Last update posted Sep 2, 2016
Countries Belgium, Cyprus, Czechia, France, Ireland, Italy, Luxembourg, Netherlands, Poland, Spain, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies